A Study of RO4917838 (Bitopertin) in Patients With Sub-optimally Controlled Symptoms of Schizophrenia (WN25305)



Status:Completed
Conditions:Schizophrenia
Therapuetic Areas:Psychiatry / Psychology
Healthy:No
Age Range:18 - Any
Updated:8/3/2016
Start Date:December 2010
End Date:March 2015

Use our guide to learn which trials are right for you!

Phase III, Multi-center, Randomized, 12-week, Double-blind, Parallel-group, Placebo-controlled Study to Evaluate the Efficacy and Safety of RO4917838 in Patients With Sub-optimally Controlled Symptoms of Schizophrenia Treated With Antipsychotics Followed by a 40-week Double-blind, Parallel-group, Placebo-controlled Treatment Period.

This randomized, multi-center double-blind, parallel-group, placebo-controlled study will
evaluate the efficacy and safety of RO4917838 (bitopertin) in patients with sub-optimally
controlled symptoms of schizophrenia. Patients, on stable treatment with antipsychotics,
will be randomized to receive daily oral doses of RO4917838 or matching placebo for 52
weeks, followed by an optional treatment extension for up to 3 years.


Inclusion Criteria:

- Adult patients, >/= 18 years of age

- Diagnosis of schizophrenia

- Clinical stability for 16 weeks (4 months) prior to randomization

- Antipsychotic treatment stability for the past 12 weeks prior to randomization

- With the exception of clozapine, patients are on any of the available marketed
atypical or typical antipsychotic (treatment with a maximum of two antipsychotics)

Exclusion Criteria:

- Has treatment resistant schizophrenia as judged by the treating physician OR have
failed two trials

- Evidence that patient has clinically significant uncontrolled or unstable medical
disorder (e.g. cardiovascular, renal hepatic, gastrointestinal, hematologic,
immunological, neurological, endocrine, metabolic or pulmonary disease)

- Patient has a body mass index (BMI) of <17 or >40 kg/m2, respectively)

- Diagnosis of mental retardation or severe organic brain syndromes

- In the investigator's judgment, a significant risk of suicide or violent behavior"
We found this trial at
23
sites
?
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
?
mi
from
Atlanta, GA
Click here to add this to my saved trials
?
mi
from
Austin, TX
Click here to add this to my saved trials
?
mi
from
Bourgas,
Click here to add this to my saved trials
?
mi
from
Buffalo, NY
Click here to add this to my saved trials
?
mi
from
Costa Mesa, CA
Click here to add this to my saved trials
?
mi
from
Durham, NC
Click here to add this to my saved trials
?
mi
from
Escondido, CA
Click here to add this to my saved trials
?
mi
from
Flowood, MS
Click here to add this to my saved trials
Granada Hills, California 91344
?
mi
from
Granada Hills, CA
Click here to add this to my saved trials
?
mi
from
Indianapolis, IN
Click here to add this to my saved trials
?
mi
from
Irving, TX
Click here to add this to my saved trials
?
mi
from
La Jolla, CA
Click here to add this to my saved trials
?
mi
from
Las Vegas, NV
Click here to add this to my saved trials
?
mi
from
Lauderhill, FL
Click here to add this to my saved trials
?
mi
from
New York, NY
Click here to add this to my saved trials
?
mi
from
Oceanside, CA
Click here to add this to my saved trials
?
mi
from
Orange City, FL
Click here to add this to my saved trials
?
mi
from
Plantation, FL
Click here to add this to my saved trials
?
mi
from
Rochester, NY
Click here to add this to my saved trials
?
mi
from
San Diego, CA
Click here to add this to my saved trials
?
mi
from
Scranton, PA
Click here to add this to my saved trials
?
mi
from
Torrance, CA
Click here to add this to my saved trials